Informations générales (source: ClinicalTrials.gov)
Evaluation of Indocyanine Green Fluorescent Cholangiography Versus Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy: Randomized Controlled Study (CAMFIB)
Interventional
Phase 3
Centre Hospitalier Universitaire, Amiens (Voir sur ClinicalTrials)
juillet 2013
août 2018
29 juin 2024
The aim of the present study is to evaluate whether the use of indocyanine green
fluorescent cholangiography is responsible in a decrease of biliary fistula's rate in
patients with liver diseases requiring liver resection.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Amiens University Hospital - Amiens - France | jean marc regimbeau, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- benin or malignant liver disease with resection of 2 or more segments
- liver resection by laparotomy
- written consent
- benin or malignant liver disease with resection of 2 or more segments
- liver resection by laparotomy
- written consent
- previous hepatectomy
- emergency surgery
- allergy to indocyanine green
- allergy to methylene blue
- pregnancy or breastfeeding